Inactive

This new requirement is for the testing and evaluation of a proprietary antibacterial compound and compound derivatives in specialized murine in vivo models developed by the University of Virginia (UV... This new requirement is for the testing and evaluation of a proprietary antibacterial compound and compound derivatives in specialized murine in vivo models developed by the University of Virginia (UVA). The contractor will conduct research and development of the proprietary antibacterial compound, derivatives as antibacterial therapeutics, and all information gained from the in vivo studies performed by UVA, will be provided to WRAIR for the next round of structure-based drug design.